Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Tumor lysis syndrome (TLS), seen predominantly in hematologic malignancies, is an emerging but rare complication in lung cancer with high mortality, reaching 21% in solid tumors overall. TLS ...

Tumor Lysis Syndrome (TLS) CAR T-cell therapy releases millions of new T cells into your body to kill your cancer cells.

A pharmacist-led clinic was able to safely and effectively manage venetoclax ramp-up for patients with chronic lymphocytic leukemia (CLL) at low to moderate risk for tumor lysis syndrome (TLS ...

Tumor lysis syndrome Chemotherapy causes the outer membrane of cancer cells to break down and release their cell contents. These contents include elements such as: ...

Between December 2022 and November 2023, Dr. Iwasaki and her team collected blood samples from 42 people with post-vaccination syndrome and 22 healthy people without it. People with the syndrome ...

Abstract 122 Background: Tumor lysis syndrome (TLS) is an oncologic emergency resulting from the release of potassium, phosphorus, and nucleic acids from tumor cells. While rare in colorectal cancer ...

Yannis K. Valtis, MD, second-year fellow in medical oncology at Memorial Sloan Kettering Cancer Center, provides background on a single-institution, retrospective cohort study which assessed ...

Spontaneous Tumor Lysis Syndrome (STLS) is a rare oncologic condition caused by the breakdown of neoplastic tissue in the absence of traditional anti-tumor therapy. It is postulated that cancers with ...